MENU

DHR Stock Danaher (DHR, $207.95) RSI Indicator left the oversold zone on February 20, 2025

A.I.dvisor
at Tickeron.com
Loading...
DHR - Danaher Corp
RSI signal
Bullish Trend
Odds of UP Trend
Tickeron
RSI signal
Price: $207.95
Daily change: +$2.97 (+1.45%)
Daily volume: 4.7M
Capitalization: $149.5B
Industry: Medical Specialties
This is a signal that DHR's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options. A.I.dvisor looked back and found 26 similar cases where DHR's RSI Indicator left the oversold zone, and in of them led to a successful outcome. Odds of Success:

DHR in upward trend: price expected to rise as it breaks its lower Bollinger Band on February 03, 2025

DHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 34 cases where DHR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where DHR's RSI Indicator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 53 cases where DHR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on February 21, 2025. You may want to consider a long position or call options on DHR as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DHR just turned positive on February 21, 2025. Looking at past instances where DHR's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DHR advanced for three days, in of 336 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 310 cases where DHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

DHR moved below its 50-day moving average on January 29, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for DHR crossed bearishly below the 50-day moving average on February 04, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. DHR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.431) is normal, around the industry mean (23.448). P/E Ratio (43.857) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (3.229) is also within normal values, averaging (5.667). Dividend Yield (0.004) settles around the average of (0.018) among similar stocks. P/S Ratio (7.710) is also within normal values, averaging (41.230).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of industrial instruments and machinery

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
2200 Pennsylvania Avenue, N.W.
Phone
+1 202 828-0850
Employees
63000
Web
https://www.danaher.com